MRI-Trackable Mesenchymal Stem Cells for Oncolytic Therapy: A Clinically Feasible Dual-Labeling Protocol
Harshan Ravi, Deborah R. Healey, Neha Damodar, Ellen Ackerstaff, Joy Gumin, Daniel Ledbetter, Frederick F. Lang, Elizabeth J. Shpall, Mayela Mendt Vilchez, Shian-Jy Wang, C. Chad Quarles
This study evaluates a dual-labeling protocol for mesenchymal stem cells with iron oxide particles and an oncolytic virus, showing preserved cellular function and MRI detectability.
bioRxiv · Oct 20, 2026 · PreprintBioengineering